Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.
Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, Karikari TK, Blennow K, Zetterberg H, Jedynak BM, Thambisetty M, Ferrucci L, Resnick SM. Bilgel M, et al. Among authors: blennow k. medRxiv [Preprint]. 2023 Apr 21:2023.01.12.23284439. doi: 10.1101/2023.01.12.23284439. medRxiv. 2023. Update in: Alzheimers Dement. 2023 Oct;19(10):4335-4345. doi: 10.1002/alz.13157 PMID: 36711545 Free PMC article. Updated. Preprint.
Revealing the combined roles of Aβ and tau in Alzheimer's disease via a pathophysiological activity decoder.
Sanchez-Rodriguez LM, Bezgin G, Carbonell F, Therriault J, Fernandez-Arias J, Servaes S, Rahmouni N, Tissot C, Stevenson J, Karikari TK, Ashton NJ, Benedet AL, Zetterberg H, Blennow K, Triana-Baltzer G, Kolb HC, Rosa-Neto P, Iturria-Medina Y. Sanchez-Rodriguez LM, et al. Among authors: blennow k. bioRxiv [Preprint]. 2023 Jul 20:2023.02.21.529377. doi: 10.1101/2023.02.21.529377. bioRxiv. 2023. PMID: 37502947 Free PMC article. Preprint.
PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer's disease.
Poirier A, Picard C, Labonté A, Aubry I, Auld D, Zetterberg H, Blennow K; PREVENT-AD research group; Tremblay ML, Poirier J. Poirier A, et al. Among authors: blennow k. bioRxiv [Preprint]. 2024 May 12:2024.05.12.593733. doi: 10.1101/2024.05.12.593733. bioRxiv. 2024. Update in: Sci Rep. 2024 Jun 26;14(1):14718. doi: 10.1038/s41598-024-65104-2 PMID: 38766183 Free PMC article. Updated. Preprint.
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease.
Lizama BN, North HA, Pandey K, Williams C, Duong D, Cho E, Di Caro V, Ping L, Blennow K, Zetterberg H, Lah J, Levey AI, Grundman M, Caggiano AO, Seyfried NT, Hamby ME. Lizama BN, et al. Among authors: blennow k. Neurobiol Dis. 2024 Sep;199:106575. doi: 10.1016/j.nbd.2024.106575. Epub 2024 Jun 22. Neurobiol Dis. 2024. PMID: 38914170 Free article. Clinical Trial.
Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression.
Duggan MR, Gomez GT, Joynes CM, Bilgel M, Chen J, Fattorelli N, Hohman TJ, Mancuso R, Cordon J, Castellano T, Koran MEI, Candia J, Lewis A, Moghekar A, Ashton NJ, Kac PR, Karikari TK, Blennow K, Zetterberg H, Martinez-Muriana A, De Strooper B, Thambisetty M, Ferrucci L, Gottesman RF, Coresh J, Resnick SM, Walker KA. Duggan MR, et al. Among authors: blennow k. Brain Behav Immun. 2024 Aug;120:604-619. doi: 10.1016/j.bbi.2024.07.002. Epub 2024 Jul 6. Brain Behav Immun. 2024. PMID: 38977137 Free article.
2,184 results